Ledger.Open graph →
SEC Form D · filed January 3, 2022

Bond Biosciences, Inc

Offering
$10.0M
Sold
$6.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Timothy A. Opler · New York, NYDirectorMichael A. Riley · New York, NYExec · DirectorCory A. Berkland · New York, NYExec · DirectorMichael A. Beckloff · New York, NYDirectorFred Ehrsam · Austin, TXDirectorJustin Ross · Austin, TXExec · DirectorScott Kavanaugh · Dallas, TXExec · DirectorChad Collishaw · Austin, TXExec · DirectorEddie R. Hutton · SHANNON, MSDirectorCruz Sierra · Austin, TXExec · DirectorMichael A. Beckloff · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗